Arthroplasty Today (Dec 2020)

Long-Term Outcomes of the Knee and Hip Arthroplasties in Patients with Alkaptonuria

  • Jihad M. Al-Ajlouni, MD, FRCS,
  • Mohammed S. Alisi, MD,
  • Mohamad S. Yasin, MD,
  • Aws Khanfar, MD,
  • Mohammad Hamdan, MD,
  • Ahmad Abu Halaweh, MD,
  • Hashem Al Hawamdeh, MD,
  • Khamis Elessi, MSc-EBM,
  • Mohammad S. Alsbou, MD, PhD

Journal volume & issue
Vol. 6, no. 4
pp. 689 – 693

Abstract

Read online

Alkaptonuria is a rare autosomal recessive metabolic disorder. It is characterized by the accumulation of homogentisic acid in the body due to a lack of enzymes that degrade it. Over time, it results in joint degeneration and eventually leads to ochronosis. Ochronosis refers to bluish-black discoloration of connective and other tissues within the body. In this study, we present 5 distinct cases diagnosed with alkaptonuria. They have undergone 8 total joint replacement surgeries (4 hips and 4 knees) within 8 years (2010-2018). All patients had an excellent outcome over several years. The follow-up period ranged from 2 to 10 years. Although none of the presented cases had intraoperative or postoperative adverse sequelae, we must take care when dealing with patients with ochronotic arthropathy. They carry a higher risk of complications than other patients with osteoarthritis disease. These complications include fractures due to fragile bone quality, muscle or tendon rupture, joint instability, and anesthesia-related complications. Total joint arthroplasty is a valid and safe option in the management of hip and knee ochronotic arthropathy.

Keywords